Selected research
Market Structure
Global Electroporation / Transfection Instruments Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Electroporation / Transfection Instruments market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Electroporation / Transfection Instruments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Electroporation / Transfection Instruments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Electroporation / Transfection Instruments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Electroporation / Transfection Instruments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Electroporation / Transfection Instruments include Bio-Rad, Thermo Fisher Scientific, Nepa Gene, BTX, Lonza, BEX, STEMCELL, Labtron and MaxCyte, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Electroporation / Transfection Instruments market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Electroporation / Transfection Instruments and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Electroporation / Transfection Instruments sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Electroporation / Transfection Instruments market size, projected growth trends, production technologies, key applications, and end-use industries.
Electroporation / Transfection Instruments Segment by Company
Bio-Rad
Thermo Fisher Scientific
Nepa Gene
BTX
Lonza
BEX
STEMCELL
Labtron
MaxCyte
Celetrix Biotechnologies
Biontex
Electroporation / Transfection Instruments Segment by Type
Eukaryotic Cell
Prokaryotic Cell
Others
Electroporation / Transfection Instruments Segment by Application
Life Sciences Research
Biopharmaceuticals & Gene Therapy
Agriculture & Plant Sciences
Others
Electroporation / Transfection Instruments Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Electroporation / Transfection Instruments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Electroporation / Transfection Instruments and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Electroporation / Transfection Instruments.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Electroporation / Transfection Instruments market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Electroporation / Transfection Instruments manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Electroporation / Transfection Instruments in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Electroporation / Transfection Instruments in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Eukaryotic Cell
- Prokaryotic Cell
- Others
Applications
- Life Sciences Research
- Biopharmaceuticals & Gene Therapy
- Agriculture & Plant Sciences
- Others
Companies covered
- Bio-Rad
- Thermo Fisher Scientific
- Nepa Gene
- BTX
- Lonza
- BEX
- STEMCELL
- Labtron
- MaxCyte
- Celetrix Biotechnologies
- Biontex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Electroporation / Transfection Instruments Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Electroporation / Transfection Instruments Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Electroporation / Transfection Instruments Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Electroporation / Transfection Instruments Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Electroporation / Transfection Instruments Market Dynamics
- 2.1 Electroporation / Transfection Instruments Industry Trends
- 2.2 Electroporation / Transfection Instruments Industry Drivers
- 2.3 Electroporation / Transfection Instruments Industry Opportunities and Challenges
- 2.4 Electroporation / Transfection Instruments Industry Restraints
3 Electroporation / Transfection Instruments Market by Manufacturers
- 3.1 Global Electroporation / Transfection Instruments Revenue by Manufacturers (2021-2026)
- 3.2 Global Electroporation / Transfection Instruments Sales by Manufacturers (2021-2026)
- 3.3 Global Electroporation / Transfection Instruments Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Electroporation / Transfection Instruments Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Electroporation / Transfection Instruments Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Electroporation / Transfection Instruments Manufacturers, Product Type & Application
- 3.7 Global Electroporation / Transfection Instruments Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Electroporation / Transfection Instruments Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Electroporation / Transfection Instruments Players Market Share by Revenue in 2025
- 3.8.3 2025 Electroporation / Transfection Instruments Tier 1, Tier 2, and Tier 3
4 Electroporation / Transfection Instruments Market by Type
- 4.1 Electroporation / Transfection Instruments Type Introduction
- 4.1.1 Eukaryotic Cell
- 4.1.2 Prokaryotic Cell
- 4.1.3 Others
- 4.2 Global Electroporation / Transfection Instruments Sales by Type
- 4.2.1 Global Electroporation / Transfection Instruments Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Electroporation / Transfection Instruments Sales by Type (2021-2032)
- 4.2.3 Global Electroporation / Transfection Instruments Sales Market Share by Type (2021-2032)
- 4.3 Global Electroporation / Transfection Instruments Revenue by Type
- 4.3.1 Global Electroporation / Transfection Instruments Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Electroporation / Transfection Instruments Revenue by Type (2021-2032)
- 4.3.3 Global Electroporation / Transfection Instruments Revenue Market Share by Type (2021-2032)
5 Electroporation / Transfection Instruments Market by Application
- 5.1 Electroporation / Transfection Instruments Application Introduction
- 5.1.1 Life Sciences Research
- 5.1.2 Biopharmaceuticals & Gene Therapy
- 5.1.3 Agriculture & Plant Sciences
- 5.1.4 Others
- 5.2 Global Electroporation / Transfection Instruments Sales by Application
- 5.2.1 Global Electroporation / Transfection Instruments Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Electroporation / Transfection Instruments Sales by Application (2021-2032)
- 5.2.3 Global Electroporation / Transfection Instruments Sales Market Share by Application (2021-2032)
- 5.3 Global Electroporation / Transfection Instruments Revenue by Application
- 5.3.1 Global Electroporation / Transfection Instruments Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Electroporation / Transfection Instruments Revenue by Application (2021-2032)
- 5.3.3 Global Electroporation / Transfection Instruments Revenue Market Share by Application (2021-2032)
6 Global Electroporation / Transfection Instruments Sales by Region
- 6.1 Global Electroporation / Transfection Instruments Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Electroporation / Transfection Instruments Sales by Region (2021-2032)
- 6.2.1 Global Electroporation / Transfection Instruments Sales by Region (2021-2026)
- 6.2.2 Global Electroporation / Transfection Instruments Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Electroporation / Transfection Instruments Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Electroporation / Transfection Instruments Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Electroporation / Transfection Instruments Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Electroporation / Transfection Instruments Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Electroporation / Transfection Instruments Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Electroporation / Transfection Instruments Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Electroporation / Transfection Instruments Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Electroporation / Transfection Instruments Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Electroporation / Transfection Instruments Revenue by Region
- 7.1 Global Electroporation / Transfection Instruments Revenue by Region
- 7.1.1 Global Electroporation / Transfection Instruments Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Electroporation / Transfection Instruments Revenue by Region (2021-2026)
- 7.1.3 Global Electroporation / Transfection Instruments Revenue by Region (2027-2032)
- 7.1.4 Global Electroporation / Transfection Instruments Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Electroporation / Transfection Instruments Revenue (2021-2032)
- 7.2.2 North America Electroporation / Transfection Instruments Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Electroporation / Transfection Instruments Revenue (2021-2032)
- 7.3.2 Europe Electroporation / Transfection Instruments Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Electroporation / Transfection Instruments Revenue (2021-2032)
- 7.4.2 Asia-Pacific Electroporation / Transfection Instruments Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Electroporation / Transfection Instruments Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Electroporation / Transfection Instruments Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bio-Rad
- 8.1.1 Bio-Rad Company Information
- 8.1.2 Bio-Rad Business Overview
- 8.1.3 Bio-Rad Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bio-Rad Electroporation / Transfection Instruments Product Portfolio
- 8.1.5 Bio-Rad Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Electroporation / Transfection Instruments Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Nepa Gene
- 8.3.1 Nepa Gene Company Information
- 8.3.2 Nepa Gene Business Overview
- 8.3.3 Nepa Gene Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Nepa Gene Electroporation / Transfection Instruments Product Portfolio
- 8.3.5 Nepa Gene Recent Developments
- 8.4 BTX
- 8.4.1 BTX Company Information
- 8.4.2 BTX Business Overview
- 8.4.3 BTX Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 BTX Electroporation / Transfection Instruments Product Portfolio
- 8.4.5 BTX Recent Developments
- 8.5 Lonza
- 8.5.1 Lonza Company Information
- 8.5.2 Lonza Business Overview
- 8.5.3 Lonza Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Lonza Electroporation / Transfection Instruments Product Portfolio
- 8.5.5 Lonza Recent Developments
- 8.6 BEX
- 8.6.1 BEX Company Information
- 8.6.2 BEX Business Overview
- 8.6.3 BEX Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 BEX Electroporation / Transfection Instruments Product Portfolio
- 8.6.5 BEX Recent Developments
- 8.7 STEMCELL
- 8.7.1 STEMCELL Company Information
- 8.7.2 STEMCELL Business Overview
- 8.7.3 STEMCELL Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 STEMCELL Electroporation / Transfection Instruments Product Portfolio
- 8.7.5 STEMCELL Recent Developments
- 8.8 Labtron
- 8.8.1 Labtron Company Information
- 8.8.2 Labtron Business Overview
- 8.8.3 Labtron Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Labtron Electroporation / Transfection Instruments Product Portfolio
- 8.8.5 Labtron Recent Developments
- 8.9 MaxCyte
- 8.9.1 MaxCyte Company Information
- 8.9.2 MaxCyte Business Overview
- 8.9.3 MaxCyte Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 MaxCyte Electroporation / Transfection Instruments Product Portfolio
- 8.9.5 MaxCyte Recent Developments
- 8.10 Celetrix Biotechnologies
- 8.10.1 Celetrix Biotechnologies Company Information
- 8.10.2 Celetrix Biotechnologies Business Overview
- 8.10.3 Celetrix Biotechnologies Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Celetrix Biotechnologies Electroporation / Transfection Instruments Product Portfolio
- 8.10.5 Celetrix Biotechnologies Recent Developments
- 8.11 Biontex
- 8.11.1 Biontex Company Information
- 8.11.2 Biontex Business Overview
- 8.11.3 Biontex Electroporation / Transfection Instruments Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Biontex Electroporation / Transfection Instruments Product Portfolio
- 8.11.5 Biontex Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Electroporation / Transfection Instruments Value Chain Analysis
- 9.1.1 Electroporation / Transfection Instruments Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Electroporation / Transfection Instruments Production Mode & Process
- 9.2 Electroporation / Transfection Instruments Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Electroporation / Transfection Instruments Distributors
- 9.2.3 Electroporation / Transfection Instruments Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst